Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
Oncolytic viruses induce a variety of immune targets in the infected tumours. Here, the authors show that Newcastle Disease Virus (NDV) upregulates the inducible co-stimulator (ICOS) on T cells and that intratumoral targeting of ICOS with engineered NDV in combination with CTLA-4 blockade induces sy...
Guardado en:
Autores principales: | Dmitriy Zamarin, Rikke B. Holmgaard, Jacob Ricca, Tamar Plitt, Peter Palese, Padmanee Sharma, Taha Merghoub, Jedd D. Wolchok, James P. Allison |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14d00d2c8ae14d72b432b19c11c9bf8b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Edurne Rujas, et al.
Publicado: (2020) -
ICO AND STO AS MODERN TOOLS FOR CROWDFUNDING STARTUPS
por: A. V. Kozhanova
Publicado: (2020) -
Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
por: Yi Wang, et al.
Publicado: (2021) -
Initial Coin Offerings (ICOs): benefits, risks and success measures
por: Alfreda Šapkauskienė, et al.
Publicado: (2020) -
LEGAL APPROACHES FOR THE REGULATION OF CRYPTOCURRENCY AND ICO IN FOREIGN COUNTRIES AND THE EUROPEAN UNION
por: N. Efimova
Publicado: (2018)